• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性肺病:肺生长背景下的病理生理学。

Interstitial lung disease: physiopathology in the context of lung growth.

机构信息

Inserm, UMR-S U938, Paris, F-75012 France.

出版信息

Paediatr Respir Rev. 2011 Dec;12(4):216-22. doi: 10.1016/j.prrv.2011.04.003. Epub 2011 May 18.

DOI:10.1016/j.prrv.2011.04.003
PMID:22018034
Abstract

Interstitial lung diseases (ILDs) in children represent a heterogeneous group of respiratory disorders characterized by derangements of the alveolar walls. The key pathologic feature of ILDs is the altered repair of the alveolar surface after injury with a marked disruption in the integrity of the epithelium and, consequently, a dysregulated communication between epithelial and mesenchymal pulmonary components. Concomitant to the loss of cell-cell contact, epithelial cells undergo a process called epithelial to mesenchymal transition and acquire a mesenchymal identity. Among the factors involved in disease progression, transforming growth factor-β has been identified as a master switch in the induction of fibrosis. This article reviews recent advances in the understanding of the mechanisms involved in the pathogenesis of ILDs, and provides information on their adaptation in the context of lung growth.

摘要

儿童间质性肺疾病(ILDs)代表了一组异质性的呼吸系统疾病,其特征是肺泡壁的紊乱。ILDs 的主要病理特征是肺泡表面在损伤后的异常修复,上皮完整性明显中断,因此上皮和间充质肺成分之间的通讯失调。伴随着细胞-细胞接触的丧失,上皮细胞经历一个称为上皮-间充质转化的过程,并获得间充质特征。在参与疾病进展的因素中,转化生长因子-β已被确定为纤维化诱导的主开关。本文综述了ILDs 发病机制中相关机制的最新研究进展,并提供了关于其在肺生长背景下适应性的信息。

相似文献

1
Interstitial lung disease: physiopathology in the context of lung growth.间质性肺病:肺生长背景下的病理生理学。
Paediatr Respir Rev. 2011 Dec;12(4):216-22. doi: 10.1016/j.prrv.2011.04.003. Epub 2011 May 18.
2
Lung alveolar epithelium and interstitial lung disease.肺泡上皮与间质性肺疾病
Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1643-51. doi: 10.1016/j.biocel.2009.02.009. Epub 2009 Feb 23.
3
The pathogenesis of interstitial lung diseases in children.
Paediatr Respir Rev. 2004 Jun;5(2):94-7. doi: 10.1016/j.prrv.2004.01.002.
4
TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1).原代小鼠细支气管肺泡上皮细胞和间充质细胞中肿瘤坏死因子-α(TNF-α)、血小板衍生生长因子(PDGF)和转化生长因子-β1(TGF-β1)的表达:TNF-α诱导TGF-β1。
Exp Mol Pathol. 2001 Aug;71(1):13-33. doi: 10.1006/exmp.2001.2376.
5
Macrolides: new therapeutic perspectives in lung diseases.大环内酯类药物:肺部疾病的新治疗前景。
Int J Biochem Cell Biol. 2011 Sep;43(9):1241-6. doi: 10.1016/j.biocel.2011.05.009. Epub 2011 May 23.
6
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).转化生长因子-β1诱导人肺泡上皮细胞向间充质细胞转化(EMT)。
Respir Res. 2005 Jun 9;6(1):56. doi: 10.1186/1465-9921-6-56.
7
Cell-specific regulation of gamma-glutamylcysteine synthetase in human interstitial lung diseases.人间质性肺疾病中γ-谷氨酰半胱氨酸合成酶的细胞特异性调控
Hum Pathol. 2004 Jul;35(7):832-9. doi: 10.1016/j.humpath.2004.03.010.
8
[Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease].[特发性间质性肺炎/特发性肺纤维化的发病机制:疾病的细胞与分子生物学]
Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Dec;31 Suppl:20-31.
9
Epithelial cell apoptosis and lung remodeling.上皮细胞凋亡与肺重塑。
Cell Mol Immunol. 2007 Dec;4(6):419-29.
10
Interstitial lung diseases in infants and children.婴幼儿间质性肺疾病
Eur Respir J. 2008 Mar;31(3):658-66. doi: 10.1183/09031936.00004707.

引用本文的文献

1
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.尼达尼布治疗儿童和青少年肺纤维化间质性肺疾病。
Eur Respir J. 2023 Feb 2;61(2). doi: 10.1183/13993003.01512-2022. Print 2023 Feb.
2
Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis.儿童间质性肺病和小儿肺纤维化临床试验方法探讨
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1219-1227. doi: 10.1164/rccm.201903-0544CI.
3
Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
初治晚期非小细胞肺癌患者的间质性肺异常与较短生存期相关。
Eur J Radiol. 2015 May;84(5):998-1004. doi: 10.1016/j.ejrad.2015.01.021. Epub 2015 Feb 7.
4
Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice.抑瘤素M过表达可诱导抗纤维化的BALB/c小鼠肺组织中的基质沉积、信号转导和转录激活因子3(STAT3)激活以及SMAD1失调。
Lab Invest. 2014 Sep;94(9):1003-16. doi: 10.1038/labinvest.2014.81. Epub 2014 Jun 16.
5
Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts.TRPM7 通道的抑制可防止人肺成纤维细胞的增殖和分化。
Inflamm Res. 2013 Nov;62(11):961-70. doi: 10.1007/s00011-013-0653-9. Epub 2013 Aug 11.
6
Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.两兄弟的间质性肺病与新型复合杂合 ABCA3 突变。
Eur J Pediatr. 2013 Jul;172(7):953-7. doi: 10.1007/s00431-013-1977-8. Epub 2013 Feb 27.